Treatment of children with recurrent high grade gliomas with a bevacizumab containing regimen

By Parekh Chintan   Jubran Rima   Erdreich-Epstein Anat   Panigrahy Ashok   Bluml Stefan   Finlay Jonathan   Dhall Girish  

Journal of Neuro-Oncology, Vol. 103, Iss. 3, 2011-07 ,pp. : 673-680

Springer Publishing Company

Access to resources Recommend Favorite

Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option

By Flieger Maya   Ganswindt Ute   Schwarz Silke   Kreth Friedrich-Wilhelm   Tonn Jörg-Christian   Fougère Christian   Ertl Lorenz   Linn Jennifer   Herrlinger Ulrich   Belka Claus   Niyazi Maximilian  

Journal of Neuro-Oncology, Vol. 117, Iss. 2, 2014-04 ,pp. : 337-345

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan

By Zuniga R.   Torcuator R.   Jain R.   Anderson J.   Doyle T.   Ellika S.   Schultz L.   Mikkelsen T.  

Journal of Neuro-Oncology, Vol. 91, Iss. 3, 2009-02 ,pp. : 329-336

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas

By Peereboom David   Supko Jeffrey   Carson Kathryn   Batchelor Tracy   Phuphanich Surasak   Lesser Glenn   Mikkelsen Tom   Fisher Joy   Desideri Serena   He Xiaoying   Grossman Stuart  

Journal of Neuro-Oncology, Vol. 100, Iss. 2, 2010-11 ,pp. : 269-269

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas

By van den Bent M.J.   Schellens J.H.M.   Vecht C.J.   Sillevis Smit P.A.E.   Loosveld O.J.L.   Ma J.   Tijssen C.C.   Jansen R.L.H.   Kros J.M.   Verweij J.  

European Journal of Cancer, Vol. 34, Iss. 10, 1998-09 ,pp. : 1570-1574

Elsevier

Access to resources Recommend Favorite